UCSF to dedicate Mission Bay
UCSF will officially launch its new UCSF Mission Bay Campus with a festive celebration and dedication ceremony on Tuesday, October 28.
University of California San Francisco
Displaying 15991 - 16020 of 16508
-
-
UCSF School of Dentistry receives major award to study Sjogren's syndrome
The UCSF School of Dentistry has received a five-year $11.9 million award to establish an international registry network to study Sjögren's (SHOW grens) syndrome, an immulogic disorder.
-
Common drug, administered promptly, reduces incidence of post-traumatic stress disorder (ptsd), small study finds
A common drug administered in the first hours following trauma to patients deemed to be at risk of developing post-traumatic stress disorder (PTSD) reduced the occurrence of PTSD, according to a study led by researchers at the University of Lille, France.
-
Rates of early kidney disease equal between black and white Americans, but blacks five times as likely to progress to kidney failure
It's long been known that black Americans are four to five times as likely as white Americans to suffer from kidney disease that is severe enough to require dialysis or transplantation.
-
US doctors perform more than twice as many surgical biopsies to find the same number of breast cancer
Although the rate of breast cancer detection is similar in the two countries, US doctors perform two to three times more open surgical biopsies than British doctors.
-
UCSF Testing Medical Marijuana for Cancer Pain
UCSF researchers are conducting a study to determine if it is safe and effective to use smoked marijuana in combination with opioid pain medications to treat cancer pain.
-
UCSF vascular surgeons develop new technique to repair aortic arch aneurysm
A novel treatment developed by UCSF vascular surgeons has been used in a first-of-its-kind operation to repair a life-threatening aneurysm in the patient's aortic arch, which carries blood from the heart.
-
Many women can safely extend cervical cancer screening interval to three years
Many women can safely extend their cervical cancer screening interval to three years, according to a new study published in The New England Journal of Medicine.
-
Proteomics advance: scientists determine identity, cell locale and quantity of nearly all proteins
UCSF scientists have developed a set of powerful tools that allow researchers to look in unprecedented detail at the full complement of thousands of proteins acting and interacting in a living organism.
-
New Bay Area center will unite local experts in breast cancer research
A new federally funded Bay Area center will bring together local health experts to investigate possible environmental links to breast cancer and the high incidence of the disease in some regional counties.
-
Study raises doubts about ability of bone marrow-derived adult stem cells to differentiate in heart
A study led by UCSF investigators indicates that bone marrow-derived cells from mice that are transplanted into other mice fuse with cells in the animals' heart, brain and liver, and take on their characteristics.
-
Airline infant safety seat rule could cause more deaths than it prevents, pediatricians say
A proposed Federal Aviation Administration (FAA) regulation that would require infant restraint seats for children under age two would likely lead to more deaths in automobile crashes than the deaths prevented in air crashes
-
HIV's assault on immune system
A UCSF-Gladstone Institute of Virology and Immunology (GIVI) Center for AIDS Research (CFAR) symposium titled, Immunology of HIV Infection will take place October 22 and 23, 2003.
-
New UCSF-based center will
A new federally funded Center, based at UCSF, will bring together local health experts to investigate possible environmental links to breast cancer and the high incidence of disease in the Bay Area.
-
Progress reported on diabetes, aging and childhood disease research
Top California scientists will report progress this week on studies of Alzheimer's Disease and other diseases of aging, as well as efforts to extend lifespan, develop cures for diabetes and improve diagnosis and treatment of childhood neurological disorders.
-
UCSF arthritis and joint replacement center will deliver comprehensive care
UCSF has opened a new Arthritis and Joint Replacement Center -- a joint effort between the departments of rheumatology and orthopedic surgery.
-
Scientists switch components in cell circuits: possible new technology, therapy
By tinkering with a few of the parts in a vital signaling circuit found in human cells, UCSF scientists have demonstrated the possibility of an entirely new technology: developing new devices or therapies by mixing and matching sub-cellular signaling components.
-
Combining osteoporosis drugs produces no added benefit
Combining two types of drugs prescribed for osteoporosis does not produce a synergistic benefit in treating the disease, according to a study headed by a UCSF researcher.
-
Researchers now on road to isolating skin stem cells
Researchers at the San Francisco VA Medical Center (SFVAMC) have taken the first major step toward isolating adult stem cells from mouse skin, having developed a test that confirms the presence and number of stem cells in a given amount of tissue.
-
UCSF begins study testing antiviral drug tenofovir to prevent HIV infection
UCSF researchers have been funded by the National Institutes of Health to study the antiretroviral drug tenofovir as a potential pre-exposure prophylaxis in Cambodia among high-risk, HIV-uninfected women.
-
Pancreatic cancer linked to developmental cell signaling pathway
Scientists at UCSF and Massachusetts General Hospital (MGH) have found strong evidence that a cell signaling pathway active in embryonic development plays a crucial role in pancreatic cancer.
-
Comfort-food cravings may be body's attempt to put brake on chronic stress
UCSF researchers have identified a biochemical feedback system in rats that could explain why some people crave comfort foods - such as chocolate chip cookies and greasy cheeseburgers - when they are chronically stressed, and why such people are apt to gain weight in the abdomen.
-
Black women receive inadequate cardiac care compared to whites despite greater risk, study finds
Researchers have had few clues as to why Black women are more likely to die from heart attacks or strokes than white women.
-
Workplace exposure a significant cause of severe respiratory disease
Workplace exposure to dust or fumes may account for as many as five million cases of emphysema, chronic bronchitis and related diseases in the U.S. - diseases that have been mainly attributed to smoking, a new University of California, San Francisco survey shows.
-
Most resistance to anti-hiv drugs created by good pill-taking patients -- not by poor pill-takers
Resistance mutations to anti-HIV medications are more likely to occur in patients who take most of their medications rather than in those who don't, according to AIDS specialists at the University of California, San Francisco.
-
Scientists map signaling molecule crucial to survival, disease
A chemical sleight of hand by UCSF scientists has pinpointed for the first time where small molecules called phosphates bind to proteins in cells, allowing them to send signals and giving organisms a way to adapt to rapidly changing conditions.
-
California HMOs treat heart attack patients as well as traditional medical plans
HMO-enrolled Medicare patients who suffered a heart attack in California fared no worse -- perhaps even a little better -- than those who were covered by fee-for-service, according to a new UCSF study.
-
Short-Term Medical Cannabis Doesn't Harm HIV+ Patients
UCSF researchers found no harmful changes in HIV virus levels in patients on combination antiretroviral therapy in a safety study looking at both smoked marijuana and dronabinol, an oral medical cannabinoid.
-
UCSF Study Finds No Harm to HIV+ Patients with Short-Term Medical Cannabis
UCSF researchers found no harmful changes in HIV virus levels in patients on combination antretroiviral therapy in a safety study looking at both smoked marijuana and dronabinol, an oral medical cannabinoid.
-
Most resistance to anti-hiv drugs created by good pill-taking patients -- not by poor pill-takers
Resistance mutations to anti-HIV medications are more likely to occur in patients who take most of their medications rather than in those who don't, according to AIDS specialists at the University of California, San Francisco.